Position in NTRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$56,190
-$1,643,160 QoQ
Shares Held
207
-98.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#697
of 844 holders
Holding Since
Dec 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $232,234,639 across 23 Diagnostics & Research names. NTRA ranks #20 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
346,489 | $73,438,343 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
51,387 | $65,647,406 | |
| 3 | CSTL |
Castle Biosciences Inc
|
918,668 | $21,910,231 | |
| 4 | FLGT |
Fulgent Genetics, Inc.
|
1,017,913 | $20,887,574 | |
| 5 | MYGN |
Myriad Genetics Inc
|
3,126,973 | $17,855,015 | |
| 6 | QGEN |
Qiagen N.V.
|
233,416 | $9,126,565 | |
| 7 | GH |
Guardant Health, Inc.
|
38,450 | $5,768,653 | |
| 8 | CDNA |
CareDx, Inc.
|
186,391 | $5,312,143 |
All Filings in NTRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,190 | 207 | Shares | Defined | 2026-08-13 | |
| 2024-12-31 | $1,699,350 | 10,735 | Shares | Defined | 2025-02-11 | |
| 2023-09-30 | $20,089 | 454 | Shares | Defined | 2023-11-13 | |
| 2022-09-30 | $76,728 | 1,751 | Shares | Defined | 2022-11-14 | |
| 2021-09-30 | $365,634 | 3,281 | Shares | Defined | 2021-11-12 | |
| 2020-12-31 | $34,135 | 343 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||